Tag: j&j medtech
J&J highlights publication of positive MEMBRANE trial results
Johnson & Johnson (J&J) recently announced the publication of the primary results from the MEMBRANE randomised controlled trial (RCT) in JAMA Neurology. The study...
J&J announces CE-mark approval for multiple Cereglide catheter sizes and Innerglide...
Johnson & Johnson (J&J) announced today that it has received CE-mark approvals for its Cereglide 42 and Cereglide 57 aspiration catheters, noting in a...
J&J adds Cereglide 42, Cereglide 57 and Innerglide 7 to stroke...
Johnson & Johnson (J&J) recently announced the US launch of the Cereglide 42 and Cereglide 57 aspiration catheters—along with the Innerglide 7 delivery aid—making...
J&J MedTech receives US FDA approval for Trufill n‑BCA liquid embolic...
Today, Johnson & Johnson (J&J) MedTech announced that the US Food and Drug Administration (FDA) has approved an expanded indication for the Trufill n‑BCA liquid...
J&J highlights neurovascular advances at ESMINT 2025 following CE-mark approval for...
Johnson & Johnson (J&J) MedTech highlighted its latest clinical and technological advancements recently at the European Society of Minimally Invasive Neurological Therapy (ESMINT) annual congress...
